# Amoxicillin-clavulanate Alone or in Combination With Ciprofloxacin in Low-Risk Febrile Neutropenic Adult Patients: A Prospective, Double-blind, Randomized, Non-Inferiority Multicenter, Phase III Clinical Trial.

> **NCT04698057** · PHASE3 · WITHDRAWN · sponsor: **Poitiers University Hospital**

## Conditions studied

- Febrile Neutropenia

## Interventions

- **DRUG:** Placebo
- **DRUG:** Amoxicillin Clavulanate
- **DRUG:** Ciprofloxacin

## Key facts

- **NCT ID:** NCT04698057
- **Lead sponsor:** Poitiers University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-03-01
- **Primary completion:** 2025-06-01
- **Final completion:** 2025-06-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No enrolment due to Covid-19
- **Last updated:** 2022-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04698057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04698057, "Amoxicillin-clavulanate Alone or in Combination With Ciprofloxacin in Low-Risk Febrile Neutropenic Adult Patients: A Prospective, Double-blind, Randomized, Non-Inferiority Multicenter, Phase III Clinical Trial.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04698057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*